American Society of Hirudotherapy

Hirudo tianjinensis Multimeric Hirudin

Multi-domain hirudin superfamily proteins from H. tianjinensis (Kalatehjari 2026) — two-or-more central globular domains per molecule.

Preclinical / mechanistic: Evidence is preclinical (in vitro, animal models, or mechanism-of-action research). Clinical efficacy in humans has not been established.Last Updated: May 27, 2026 · ASH Editorial · based on the books
  • Hementerin80 kDa
  • Hementin80 kDa
  • Hementin-Like Protein (HLP-1)80 kDa
  • Leech Collagenase70 kDa
  • Haemadipsa yanyuanensis Progranulin (Hy-PGRN)70 kDa
  • Leech Apyrase67 kDa
  • Calin65 kDa
  • Hyaluronidase60 kDa
  • Antithrombin III binding protein58 kDa
  • Collagenolytic Fibrinolysin55 kDa
  • Leech Thrombospondin-Like Protein50 kDa
  • Hirudo tianjinensis Multimeric Hirudin15 kDa
Molecular weight (kilodaltons) of Hirudo tianjinensis Multimeric Hirudin (highlighted) alongside other characterized leech salivary compounds. Smaller proteins/peptides generally diffuse and act faster.

Mechanistic Evidence Box

Preclinical / mechanistic: Evidence is preclinical (in vitro, animal models, or mechanism-of-action research). Clinical efficacy in humans has not been established.
Page type
Compound profile
Evidence type
Preclinical / biochemical characterization
Evidence level
In vitro
Drug vs leech
Recombinant (genetically expressed)
Safety domains
Bleeding

Clinical translation limit

Multimeric hirudin's in vitro thrombin inhibition does NOT establish clinical efficacy. No FDA-approved multimeric hirudin derivative exists; clinical hirudin analogs (lepirudin, desirudin) are monomeric.

Molecular Profile

Category
Anticoagulant
Evidence tier
Preclinical
Molecular weight
15,000 Da
Source species
Hirudo tianjinensis
Discovered
2026 · Kalatehjari P et al.

Biological Targets

  • → thrombin (multivalent binding via multiple globular domains)

Key Citations

  1. Kalatehjari P et al. (2026), Parasitol Res · PMID 41653280

External Resources

    Related Anticoagulant Compounds

    This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.